Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone.

Binswanger IA, Glanz JM.

Drug Saf. 2018 Oct;41(10):979-980. doi: 10.1007/s40264-018-0705-8. No abstract available.

PMID:
30073490
2.

Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents.

Jackson ML, Yu O, Nelson JC, Nordin JD, Tartof SY, Klein NP, Donahue JG, Irving SA, Glanz JM, McNeil MM, Jackson LA.

Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):921-925. doi: 10.1002/pds.4569. Epub 2018 Jun 3.

PMID:
29862604
3.

Addressing Parents' Vaccine Concerns: A Randomized Trial of a Social Media Intervention.

Daley MF, Narwaney KJ, Shoup JA, Wagner NM, Glanz JM.

Am J Prev Med. 2018 Jul;55(1):44-54. doi: 10.1016/j.amepre.2018.04.010. Epub 2018 May 14.

PMID:
29773490
4.

Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample.

Xu S, Clarke CL, Newcomer SR, Daley MF, Glanz JM.

Biom J. 2018 Jul;60(4):748-760. doi: 10.1002/bimj.201700088. Epub 2018 May 16.

PMID:
29768667
5.

Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule.

Daley MF, Shoup JA, Newcomer SR, Jackson ML, Groom HC, Jacobsen SJ, McLean HQ, Klein NP, Weintraub ES, McNeil MM, Glanz JM.

Acad Pediatr. 2018 Sep - Oct;18(7):754-762. doi: 10.1016/j.acap.2018.03.007. Epub 2018 Mar 28.

PMID:
29604461
6.

Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age.

Glanz JM, Newcomer SR, Daley MF, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McCarthy NL, McClure DL, Narwaney KJ, Nordin JD, Zerbo O.

JAMA. 2018 Mar 6;319(9):906-913. doi: 10.1001/jama.2018.0708.

7.

Infant Hospitalizations and Mortality After Maternal Vaccination.

Sukumaran L, McCarthy NL, Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Jackson L, Klein NP, Naleway AL, McClure DL, Hechter RC, Kawai AT, Glanz JM, Weintraub ES.

Pediatrics. 2018 Mar;141(3). pii: e20173310. doi: 10.1542/peds.2017-3310. Epub 2018 Feb 20.

PMID:
29463582
8.

Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines.

Wang SV, Abdurrob A, Spoendlin J, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub ES, Kulldorff M.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):405-412. doi: 10.1002/pds.4399. Epub 2018 Feb 13.

PMID:
29441647
9.

Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy.

Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA.

J Gen Intern Med. 2018 Oct;33(10):1646-1653. doi: 10.1007/s11606-017-4288-3. Epub 2018 Jan 29.

PMID:
29380216
10.

Bias from outcome misclassification in immunization schedule safety research.

Newcomer SR, Kulldorff M, Xu S, Daley MF, Fireman B, Lewis E, Glanz JM.

Pharmacoepidemiol Drug Saf. 2018 Feb;27(2):221-228. doi: 10.1002/pds.4374. Epub 2018 Jan 2.

PMID:
29292551
11.

Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults.

Storms AD, Chen J, Jackson LA, Nordin JD, Naleway AL, Glanz JM, Jacobsen SJ, Weintraub ES, Klein NP, Gargiullo PM, Fry AM.

BMC Pulm Med. 2017 Dec 16;17(1):208. doi: 10.1186/s12890-017-0552-x.

12.

The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study.

Daley MF, Clarke CL, Glanz JM, Xu S, Hambidge SJ, Donahue JG, Nordin JD, Klein NP, Jacobsen SJ, Naleway AL, Jackson ML, Lee G, Duffy J, Weintraub E.

Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):59-68. doi: 10.1002/pds.4349. Epub 2017 Nov 17.

PMID:
29148124
13.

Web-based Social Media Intervention to Increase Vaccine Acceptance: A Randomized Controlled Trial.

Glanz JM, Wagner NM, Narwaney KJ, Kraus CR, Shoup JA, Xu S, O'Leary ST, Omer SB, Gleason KS, Daley MF.

Pediatrics. 2017 Dec;140(6). pii: e20171117. doi: 10.1542/peds.2017-1117. Epub 2017 Nov 6.

PMID:
29109107
14.

Patterns of childhood immunization and all-cause mortality.

McCarthy NL, Sukumaran L, Newcomer S, Glanz J, Daley MF, McClure D, Klein NP, Irving S, Jackson ML, Lewin B, Weintraub E.

Vaccine. 2017 Dec 4;35(48 Pt B):6643-6648. doi: 10.1016/j.vaccine.2017.10.034. Epub 2017 Oct 20.

PMID:
29061349
15.

A new method to evaluate temperature vs. pH activity profiles for biotechnological relevant enzymes.

Herlet J, Kornberger P, Roessler B, Glanz J, Schwarz WH, Liebl W, Zverlov VV.

Biotechnol Biofuels. 2017 Oct 11;10:234. doi: 10.1186/s13068-017-0923-9. eCollection 2017.

16.

Effective purifying selection in ancient asexual oribatid mites.

Brandt A, Schaefer I, Glanz J, Schwander T, Maraun M, Scheu S, Bast J.

Nat Commun. 2017 Oct 12;8(1):873. doi: 10.1038/s41467-017-01002-8.

17.

Estimated rates of influenza-associated outpatient visits during 2001-2010 in 6 US integrated healthcare delivery organizations.

Zhou H, Thompson WW, Belongia EA, Fowlkes A, Baxter R, Jacobsen SJ, Jackson ML, Glanz JM, Naleway AL, Ford DC, Weintraub E, Shay DK.

Influenza Other Respir Viruses. 2018 Jan;12(1):122-131. doi: 10.1111/irv.12495. Epub 2018 Feb 15.

18.

Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.

Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, Belongia EA.

Vaccine. 2017 Sep 25;35(40):5314-5322. doi: 10.1016/j.vaccine.2017.06.069.

PMID:
28917295
19.

Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.

Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM, Weintraub ES, Belongia EA.

Vaccine. 2017 Oct 13;35(43):5872-5877. doi: 10.1016/j.vaccine.2017.08.086. Epub 2017 Sep 6.

PMID:
28888342
20.

Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule.

Daley MF, Glanz JM, Newcomer SR, Jackson ML, Groom HC, Lugg MM, McLean HQ, Klein NP, Weintraub ES, McNeil MM.

Vaccine. 2017 Apr 4;35(15):1873-1878. doi: 10.1016/j.vaccine.2017.02.058. Epub 2017 Mar 9.

PMID:
28285983
21.

Risk factors and familial clustering for fever 7-10days after the first dose of measles vaccines.

Klein NP, Lewis E, McDonald J, Fireman B, Naleway A, Glanz J, Jackson LA, Donahue JG, Jacobsen SJ, Weintraub E, Baxter R.

Vaccine. 2017 Mar 14;35(12):1615-1621. doi: 10.1016/j.vaccine.2017.02.013. Epub 2017 Feb 21.

PMID:
28233624
22.

Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain.

Mueller SR, Koester S, Glanz JM, Gardner EM, Binswanger IA.

J Gen Intern Med. 2017 Mar;32(3):277-283. doi: 10.1007/s11606-016-3895-8. Epub 2016 Oct 31.

23.

Are seagrass beds indicators of anthropogenic nutrient stress in the rocky intertidal?

Honig SE, Mahoney B, Glanz JS, Hughes BB.

Mar Pollut Bull. 2017 Jan 15;114(1):539-546. doi: 10.1016/j.marpolbul.2016.10.020. Epub 2016 Oct 13.

PMID:
27745977
24.

White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink.

Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, DeStefano F, Daley MF.

Vaccine. 2016 Feb 15;34 Suppl 1:A1-A29. doi: 10.1016/j.vaccine.2015.10.082.

PMID:
26830300
25.

Vaccine hesitancy: Causes, consequences, and a call to action.

Salmon DA, Dudley MZ, Glanz JM, Omer SB.

Vaccine. 2015 Nov 27;33 Suppl 4:D66-71. doi: 10.1016/j.vaccine.2015.09.035.

PMID:
26615171
26.

Influenza Vaccination During Pregnancy: Influenza Seasons 2002-2012, Vaccine Safety Datalink.

Groom HC, Henninger ML, Smith N, Koppolu P, Cheetham TC, Glanz JM, Hambidge SJ, Jackson LA, Kharbanda EO, Klein NP, McCarthy NL, Nordin JD, Weintraub ES, Naleway AL.

Am J Prev Med. 2016 Apr;50(4):480-488. doi: 10.1016/j.amepre.2015.08.017. Epub 2015 Oct 31.

PMID:
26526159
27.

Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children.

Glanz JM, Newcomer SR, Daley MF, McClure DL, Baxter RP, Jackson ML, Naleway AL, Lugg MM, DeStefano F.

Vaccine. 2015 Nov 27;33(48):6736-44. doi: 10.1016/j.vaccine.2015.10.076. Epub 2015 Oct 27.

PMID:
26518400
28.

Vaccine Hesitancy: Causes, Consequences, and a Call to Action.

Salmon DA, Dudley MZ, Glanz JM, Omer SB.

Am J Prev Med. 2015 Dec;49(6 Suppl 4):S391-8. doi: 10.1016/j.amepre.2015.06.009. Epub 2015 Aug 31.

PMID:
26337116
29.

Addressing Parental Vaccine Concerns: Engagement, Balance, and Timing.

Glanz JM, Kraus CR, Daley MF.

PLoS Biol. 2015 Aug 7;13(8):e1002227. doi: 10.1371/journal.pbio.1002227. eCollection 2015 Aug.

30.

Immunization Coverage Among Juvenile Justice Detainees.

Gaskin GL, Glanz JM, Binswanger IA, Anoshiravani A.

J Correct Health Care. 2015 Jul;21(3):265-75. doi: 10.1177/0885066615587790.

PMID:
26084948
31.

Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff.

Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM.

J Gen Intern Med. 2015 Dec;30(12):1837-44. doi: 10.1007/s11606-015-3394-3.

32.

A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.

Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA.

Subst Abus. 2015;36(2):240-53. doi: 10.1080/08897077.2015.1010032. Epub 2015 Mar 16. Review.

33.

Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice.

Binswanger IA, Glanz JM.

Subst Abus. 2015;36(2):141-3. doi: 10.1080/08897077.2014.991058. Epub 2015 Feb 11.

34.

Development of an interactive social media tool for parents with concerns about vaccines.

Shoup JA, Wagner NM, Kraus CR, Narwaney KJ, Goddard KS, Glanz JM.

Health Educ Behav. 2015 Jun;42(3):302-12. doi: 10.1177/1090198114557129. Epub 2014 Nov 19.

PMID:
25413375
35.

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.

McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, Nordin JD, Klein NP, Baxter R, Naleway AL, Jackson LA, Omer SB, Jacobsen SJ, DeStefano F.

Vaccine. 2014 Sep 22;32(42):5390-8. doi: 10.1016/j.vaccine.2014.07.073. Epub 2014 Aug 6. Review.

PMID:
25108215
36.

Timely versus delayed early childhood vaccination and seizures.

Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, Shoup JA, Rowhani-Rahbar A, Klein NP, Lee GM, Nelson JC, Lugg M, Naleway AL, Nordin JD, Weintraub E, DeStefano F.

Pediatrics. 2014 Jun;133(6):e1492-9. doi: 10.1542/peds.2013-3429.

37.

Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.

Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E.

Vaccine. 2014 May 23;32(25):3019-24. doi: 10.1016/j.vaccine.2014.03.063. Epub 2014 Mar 31.

PMID:
24699471
38.

Vaccinations given during pregnancy, 2002-2009: a descriptive study.

Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, Irving S, Craig Cheetham T, Nakasato C, Glanz JM, Hambidge SJ, Davis RL, Klein NP, McCarthy NL, Weintraub E.

Am J Prev Med. 2014 Feb;46(2):150-7. doi: 10.1016/j.amepre.2013.10.010.

PMID:
24439348
39.

Risk of intussusception after monovalent rotavirus vaccination.

Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, Jackson LA, DeStefano F.

N Engl J Med. 2014 Feb 6;370(6):513-9. doi: 10.1056/NEJMoa1311738. Epub 2014 Jan 14.

40.

Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design.

Xu S, Newcomer S, Nelson J, Qian L, McClure D, Pan Y, Zeng C, Glanz J.

Biom J. 2014 May;56(3):513-25. doi: 10.1002/bimj.201300012. Epub 2014 Jan 9.

PMID:
24402780
41.

Mini-Sentinel methods: framework for assessment of positive results from signal refinement.

McClure DL, Raebel MA, Yih WK, Shoaibi A, Mullersman JE, Anderson-Smits C, Glanz JM.

Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):3-8. doi: 10.1002/pds.3547. Epub 2013 Nov 25. No abstract available.

PMID:
24395545
42.

Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design.

Zeng C, Newcomer SR, Glanz JM, Shoup JA, Daley MF, Hambidge SJ, Xu S.

Am J Epidemiol. 2013 Dec 15;178(12):1750-9. doi: 10.1093/aje/kwt211. Epub 2013 Sep 27.

PMID:
24327463
43.

Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children.

Payne DC, Baggs J, Zerr DM, Klein NP, Yih K, Glanz J, Curns AT, Weintraub E, Parashar UD.

Clin Infect Dis. 2014 Jan;58(2):173-7. doi: 10.1093/cid/cit671. Epub 2013 Nov 20.

44.

Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age.

Glanz JM, Narwaney KJ, Newcomer SR, Daley MF, Hambidge SJ, Rowhani-Rahbar A, Lee GM, Nelson JC, Naleway AL, Nordin JD, Lugg MM, Weintraub ES.

JAMA Pediatr. 2013 Nov;167(11):1060-4. doi: 10.1001/jamapediatrics.2013.2353.

PMID:
24019039
45.

A mixed methods study of parental vaccine decision making and parent-provider trust.

Glanz JM, Wagner NM, Narwaney KJ, Shoup JA, McClure DL, McCormick EV, Daley MF.

Acad Pediatr. 2013 Sep-Oct;13(5):481-8. doi: 10.1016/j.acap.2013.05.030.

46.

A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy.

Sadaf A, Richards JL, Glanz J, Salmon DA, Omer SB.

Vaccine. 2013 Sep 13;31(40):4293-304. doi: 10.1016/j.vaccine.2013.07.013. Epub 2013 Jul 13. Review.

PMID:
23859839
47.

Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children.

Newcomer SR, Hambidge SJ, McClure DL, Daley MF, Klein NP, Glanz JM.

Vaccine. 2013 Aug 20;31(37):3894-8. doi: 10.1016/j.vaccine.2013.06.051. Epub 2013 Jul 2.

PMID:
23831326
48.

Patterns of care and persistence after incident elevated blood pressure.

Daley MF, Sinaiko AR, Reifler LM, Tavel HM, Glanz JM, Margolis KL, Parker E, Trower NK, Chandra M, Sherwood NE, Adams K, Kharbanda EO, Greenspan LC, Lo JC, O'Connor PJ, Magid DJ.

Pediatrics. 2013 Aug;132(2):e349-55. doi: 10.1542/peds.2012-2437. Epub 2013 Jul 1.

49.

Mortality rates and cause-of-death patterns in a vaccinated population.

McCarthy NL, Weintraub E, Vellozzi C, Duffy J, Gee J, Donahue JG, Jackson ML, Lee GM, Glanz J, Baxter R, Lugg MM, Naleway A, Omer SB, Nakasato C, Vazquez-Benitez G, DeStefano F.

Am J Prev Med. 2013 Jul;45(1):91-97. doi: 10.1016/j.amepre.2013.02.020.

PMID:
23790993
50.

Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children.

Tseng HF, Sy LS, Liu IL, Qian L, Marcy SM, Weintraub E, Yih K, Baxter R, Glanz JM, Donahue J, Naleway A, Nordin J, Jacobsen SJ.

Vaccine. 2013 May 24;31(22):2578-83. doi: 10.1016/j.vaccine.2013.03.040. Epub 2013 Apr 8.

PMID:
23579258

Supplemental Content

Support Center